Zacks Research Downgrades EssilorLuxottica (OTCMKTS:ESLOY) to Strong Sell

EssilorLuxottica (OTCMKTS:ESLOY – Get Free Report) was downgraded by investment analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued on Tuesday,Zacks.com reports.

Separately, Deutsche Bank Aktiengesellschaft started coverage on shares of EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, EssilorLuxottica has an average rating of “Moderate Buy”.

Get EssilorLuxottica alerts:

Get Our Latest Stock Report on ESLOY

EssilorLuxottica Stock Performance

ESLOY opened at $95.44 on Tuesday. The business’s 50-day moving average price is $104.93 and its two-hundred day moving average price is $129.49. EssilorLuxottica has a 1 year low of $94.28 and a 1 year high of $186.81. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70.

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Read More

• Five stocks we like better than EssilorLuxottica
• Why KB Home Could Reward Patient Investors Later
• Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
• Tesla’s New NHTSA Probe Lands at the Worst Possible Time
• Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.